secwatch.observer — SEC 8-K summary
======================================

Issuer:     FUSE GROUP HOLDING INC. (FUST)
CIK:        0001636051
Form:       8-K/A
Filed at:   2021-10-01T23:59:59+00:00
Accession:  0001185185-21-001432
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 5.01
LLM model:  deepseek-v4-flash:cloud@v2

Fuse Group issues 100M shares for E-Mo Biotech; Xie becomes 31.97% owner
------------------------------------------------------------------------

- Fuse Group acquired all of E-Mo Biotech in exchange for 100 million common shares.
- E-Mo Biotech is a development-stage vaccine/immunology/diagnostics firm with no commercial sales.
- Qiyi Xie receives 57.25M shares (31.97% of Fuse Group) and becomes largest shareholder, replacing Landbond Home.
- Shares issued to Xie under Reg D; to other sellers under Reg S; no underwriter used.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636051/000118518521001432/0001185185-21-001432-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636051/000118518521001432/fuseent20210929_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001185185-21-001432

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer